Join Cure Leukaemia’s fight to cure blood cancer for those impacted by the disease in Manchester

With a new blood cancer diagnosis every 27 seconds worldwide, Cure Leukaemia funds research nurses and clinical roles at blood cancer centres across the UK.

- 

These roles provide patients with access to innovative and potentially lifesaving treatments through clinical trials.

September is a hugely significant month in the fight against blood cancer. It marks both Blood Cancer Awareness Month and Childhood Cancer Awareness Month - a time to come together, reflect, and take action in support of the thousands of people whose lives are affected every day.

Cure Leukaemia is funding world-leading networks that are changing how blood cancer patients - both adults and children - can access cutting-edge treatments through clinical trials.

HELPING PATIENTS ACROSS MANCHESTER AND BEYOND

In Manchester at both The Christie and Manchester Royal Infirmary, the charity funds a dedicated clinical research nurse who ensures patients have access to pioneering treatments, and potentially lifesaving clinical trials.

Cure Leukaemia’s support also extends to young patients and their families. The Royal Manchester Children’s Hospital is part of The Aticus Network, a groundbreaking initiative bringing together leading centres to deliver world-class care and research opportunities.

Adam Watson's journey began with his diagnosis of acute myeloid leukaemia in 2019. For three years, he battled courageously, with his constant positivity and hope capturing the hearts of thousands across his local community and beyond. He also received treatment at the Royal Manchester Children’s Hospital.

Adam sadly passed away aged nine in 2022, surrounded by his parents, David and Sara, who have gone on to raise the profile of fighting blood cancer.